Ligand Pharmaceuticals Stock News & Updates

[WKN: A1C9RN | Symbol: LGND]
Ligand Pharmaceuticals

Geopolitics slows Wall Street record rally – Iran war drives oil above 100 USD – Mega earnings week with five of the 'Magnificent Seven' – AI euphoria propels chip stocks to new highs - Meta: China halts 2-billion-USD AI Manus deal – Verizon's new CEO turns subscriber trend

Ligand Pharmaceuticals Impresses with its High-Margin Licensing Business

Ligand Pharmaceuticals (LGND) is currently at the top of my breakout watchlist among growth stocks. The...

Ligand Pharmaceuticals: Dominance in the Biopharma Royalty Market – Licensing Revenues Expected to Increase by 23% Annually by 2030!

Ligand Pharmaceuticals stands out in the biopharmaceutical industry with a high-margin, low-risk...

Buy Alert for Ligand Pharmaceuticals: After 60% Revenue Growth, Strategic Investments are now Being Made in the Pharma Market!

Ligand Pharmaceuticals (LGND) focuses on financially and technologically supporting partner companies...

Ligand Pharmaceuticals Emphasizes Resilience in the Biotech Sector

Ligand Pharmaceuticals is a US biopharma company based in Jupiter (Florida), specializing in a licensing...

  • ‹
  • 1
  • ›